Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Achieve Life Sciences Inc
(NQ:
ACHV
)
4.430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Achieve Life Sciences Inc
< Previous
1
2
Next >
Achieve Announces Allowance of U.S. Patents for Dosing and Administration of Cytisinicline for the Treatment and Prevention of Addiction
June 03, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Product Safety
Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
June 02, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Exposures
Death
Product Safety
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 27, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
Exposures
Death
Legal
Product Safety
Achieve Life Sciences Announces Pricing of $20 Million Underwritten Public Offering
May 25, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
Exposures
Death
Legal
Product Safety
Achieve Life Sciences Announces Proposed Underwritten Public Offering
May 24, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 24, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Regulatory Compliance
Exposures
Death
Legal
Product Safety
Achieve Reports Financial Results for First Quarter 2021 and Provides Corporate Update
May 13, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
COVID-19
Death
Intellectual Property
Achieve Life Sciences to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 13, 2021
May 04, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021
April 22, 2021
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / April 22, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Product Safety
Achieve Announces Publication of the ORCA-1 Phase 2b Clinical Trial of Cytisinicline in Adult Smokers in Nicotine and Tobacco Research
April 14, 2021
Cytisinicline Up to Five Times More Likely to Result in Smoking Abstinence Compared to Placebo Phase 3 ORCA-2 Trial Currently Enrolling at 16 sites in United States SEATTLE, WA and VANCOUVER, BC /...
From
Achieve Life Sciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.